Inconterol 1 mg Tablet is a Health Canada–registered veterinary drug (DIN 02483718) held by Grey Wolf Animal Health Inc, containing Diethylstilbestrol. Health Canada lists its status as Cancelled Pre Market (status date 22 Jun 2026). Nexara Health has matched 3 registrations of Diethylstilbestrol across 2 other regulated markets, 1 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02483718 |
|---|---|
| Brand name | Inconterol |
| Active ingredient | Diethylstilbestrol |
| Strength | 1 mg |
| Dosage form | Tablet |
| Route | Oral |
| Company | Grey Wolf Animal Health Inc |
| Status | Cancelled Pre Market — 22 Jun 2026 |
| Class | Veterinary |
| ATC | |
| AHFS | 36:68.00 |
| Regulator record | Health Canada DPD entry · Product monograph |
Status and company history
Changes Health Canada has recorded for this DIN, as observed by Nexara Health's weekly DPD comparison.
| Date | Field | From | To |
|---|---|---|---|
| 2026-09-03 | Status | Approved | Cancelled Pre Market |
| 2026-09-03 | Status | Approved | Cancelled Pre Market |
Diethylstilbestrol registered in other markets
3 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Taiwan | Stilbestol Ect 1mg (Diethylstilbestrol) "Nysco" | 尼斯可股份有限公司新莊廠 | 腸溶錠 | 已註銷 | TFDA | |
| Taiwan | Stilbestrol Ect 5mg (Diethylstilbestrol) "Nysco" | 尼斯可股份有限公司新莊廠 | 腸溶錠 | 已註銷 | TFDA | |
| United States | Diethylstilbestrol | Darmerica, LLC | Powder | FDA NDC |
See every manufacturer of Diethylstilbestrol worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Inconterol (DIN 02483718) marketed in Canada?
No. Health Canada lists DIN 02483718 as Cancelled Pre Market as of 22 Jun 2026.
Who holds the Canadian licence for this product?
Grey Wolf Animal Health Inc is the company of record in the Health Canada Drug Product Database.
Is Diethylstilbestrol registered outside Canada?
Yes — Nexara Health has matched 3 registrations in 2 other markets, including 1 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02483718, status date 2026-06-22; national medicine registries: FDA NDC, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02483718, status date 2026-06-22; national medicine registries: FDA NDC, TFDA.
Health Canada Drug Product Database (DPD), DIN 02483718, status date 2026-06-22; national medicine registries: FDA NDC, TFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.